Class Action Lawsuit Filed Against Hims & Hers Health, Inc.
Bragar Eagel & Squire, P.C. is actively reaching out to investors who experienced financial losses when investing in Hims. They are particularly eager to connect with individuals who acquired shares of Hims & Hers Health, Inc. (HIMS).
Background of the Lawsuit
Bragar Eagel & Squire, P.C. has announced that a significant class action lawsuit against Hims & Hers Health, Inc. has been initiated in the United States District Court for the Northern District of California. This lawsuit covers all individuals and entities that purchased or acquired HIMS securities within the designated timeframe. The class period is defined from April 29, 2025, through June 23, 2025.
How to Participate
Investors who are interested in participating in this lawsuit should contact Bragar Eagel & Squire partners Brandon Walker or Marion Passmore. They can provide further details and guidance on your legal rights and options. Potential lead plaintiffs have until August 25, 2025, to apply for lead plaintiff status in this action.
Key Allegations in the Complaint
The complaint outlines several significant allegations against Hims & Hers Health, Inc. It asserts that during the class period, the company and its representatives made misleading statements and failed to disclose critical information regarding their business operations. Notably, it is alleged that Hims engaged in the deceptive promotion of counterfeit versions of Wegovy, which poses risks to patient safety.
Implications of the Allegations
As a consequence of these allegations, there is a substantial risk that Hims' collaboration with Novo Nordisk, a key pharmaceutical partner, may be jeopardized. The lawsuit emphasizes that the positive representations made by the defendants about the company's operations were misleading and potentially lacked a foundation in reality.
Potential Outcomes for Investors
Investors who have acquired Hims shares and believe they have been adversely affected by these events are encouraged to reach out to Bragar Eagel & Squire, P.C. They can assist you in understanding more about these allegations and your rights as an investor. It is vital for affected parties to stay informed and proactive about their investments during this lawsuit process.
Contact Information
For inquiries, you can reach out to Brandon Walker and Marion Passmore directly at Bragar Eagel & Squire, P.C. via telephone at (212) 355-4648, or through their email at investigations@bespc.com. There is no cost or obligation involved in this consultation.
About Bragar Eagel & Squire, P.C.
Bragar Eagel & Squire, P.C. is a well-respected law firm recognized nationwide with offices across multiple states. They specialize in representing both individual and institutional investors in various legal matters, including securities and commercial litigation.
Frequently Asked Questions
What is the class action lawsuit against Hims & Hers Health, Inc. about?
The lawsuit alleges that the company made misleading statements and failed to disclose important information regarding its operations and collaborations.
How can I find out if I am eligible to participate?
If you purchased Hims shares during the specified period, you may be eligible. It’s best to contact Bragar Eagel & Squire for details.
What should I do if I have suffered losses?
Contact the law firm Bragar Eagel & Squire for guidance and assistance with your situation.
What is the deadline for participating in the lawsuit?
Investors have until August 25, 2025, to apply to be appointed as lead plaintiff in this action.
Who are the lawyers involved in this case?
The primary attorneys handling this case are Brandon Walker and Marion Passmore from Bragar Eagel & Squire, P.C.
